These documents have become too technical, too inconsistent, and rely too much on expert opinion, Marco Valgimigli argues.

A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

While intensity didn’t appear to matter in this network meta-analysis, location did: in-person programs had the most impact.

It’s not yet time to abandon seated BP measurements, but taking a look at supine readings may provide enhanced risk ...